{"id":"https://openalex.org/W2425304657","doi":"https://doi.org/10.1007/s15015-016-2632-9","title":"Interferontherapie beim malignen Melanom","display_name":"Interferontherapie beim malignen Melanom","publication_year":2016,"publication_date":"2016-06-01","ids":{"openalex":"https://openalex.org/W2425304657","doi":"https://doi.org/10.1007/s15015-016-2632-9","mag":"2425304657"},"language":"de","primary_location":{"id":"doi:10.1007/s15015-016-2632-9","doi":"https://doi.org/10.1007/s15015-016-2632-9","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s15015-016-2632-9","pdf_url":"https://link.springer.com/content/pdf/10.1007%2Fs15015-016-2632-9.pdf","source":{"id":"https://openalex.org/S4210192124","display_name":"Im Focus Onkologie","issn_l":"1435-7402","issn":["1435-7402","2192-5674"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Im Focus Onkologie","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://link.springer.com/content/pdf/10.1007%2Fs15015-016-2632-9.pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5015007121","display_name":"Kathrin von Kieseritzky","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Kathrin von Kieseritzky","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":["https://openalex.org/A5015007121"],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":true,"cited_by_count":1,"citation_normalized_percentile":{"value":0.06030056,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"19","issue":"6","first_page":"43","last_page":"43"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10392","display_name":"Cutaneous Melanoma Detection and Management","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10392","display_name":"Cutaneous Melanoma Detection and Management","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11533","display_name":"Melanoma and MAPK Pathways","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/interferon-alpha-2b","display_name":"interferon alfa-2b","score":0.9210000038146973},{"id":"https://openalex.org/keywords/melanoma","display_name":"melanoma","score":0.9860000014305115},{"id":"https://openalex.org/keywords/stage-iii-melanoma","display_name":"stage III melanoma","score":0.9110000133514404},{"id":"https://openalex.org/keywords/high-dose-interferon-therapy","display_name":"high-dose interferon therapy","score":0.7979999780654907},{"id":"https://openalex.org/keywords/recurrence-prevention","display_name":"recurrence prevention","score":0.656000018119812},{"id":"https://openalex.org/keywords/adverse-effects","display_name":"adverse effects","score":0.5709999799728394}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.43434789776802063}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1007/s15015-016-2632-9","doi":"https://doi.org/10.1007/s15015-016-2632-9","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s15015-016-2632-9","pdf_url":"https://link.springer.com/content/pdf/10.1007%2Fs15015-016-2632-9.pdf","source":{"id":"https://openalex.org/S4210192124","display_name":"Im Focus Onkologie","issn_l":"1435-7402","issn":["1435-7402","2192-5674"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Im Focus Onkologie","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.1007/s15015-016-2632-9","doi":"https://doi.org/10.1007/s15015-016-2632-9","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s15015-016-2632-9","pdf_url":"https://link.springer.com/content/pdf/10.1007%2Fs15015-016-2632-9.pdf","source":{"id":"https://openalex.org/S4210192124","display_name":"Im Focus Onkologie","issn_l":"1435-7402","issn":["1435-7402","2192-5674"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Im Focus Onkologie","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.98580002784729}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2425304657.pdf","grobid_xml":"https://content.openalex.org/works/W2425304657.grobid-xml"},"referenced_works_count":1,"referenced_works":["https://openalex.org/W2120415677"],"related_works":["https://openalex.org/W2006156902","https://openalex.org/W6998668523","https://openalex.org/W1994475937","https://openalex.org/W2071781429","https://openalex.org/W1691798915","https://openalex.org/W2059275324","https://openalex.org/W2335089755","https://openalex.org/W2156249402","https://openalex.org/W3132177244","https://openalex.org/W1605093156"],"abstract_inverted_index":null,"counts_by_year":[],"updated_date":"2026-09-18T07:38:42.748307","created_date":"2016-06-24T00:00:00"}